RECAP · Reviewed 2026-05-28

Bull Rankings 2026-05-28 — Thursday, May 28

In one line: Gold sets the tone in the May 28 cut: Kinross Gold (KGC, 99) tops growth, AngloGold Ashanti (AU, 101) leads value, BILL Holdings (BILL, 90) heads the speculative book. Top 5 per bucket, re-scored against today's prices.

This refresh

Data-driven refresh May 28, 2026. Top 5 per bucket by live Bull Rankings score across a 5180-ticker universe covering every US-listed common stock on NYSE, NASDAQ, NYSE American, and NYSE Arca (2545 passed the market-cap / liquidity screen). Fundamentals sourced from Yahoo Finance quoteSummary + quarterly FCF reconstruction; narrative authored by Groq (with Gemini and data-driven fallbacks). Intraday re-ranking from a top-30 per-bucket shortlist.

Growth — high-quality compounders

1. KGC — Kinross Gold Corporation · score 99

Gold · price $28.51 · 1Y $41.23 · 5Y $45.92 · 10Y $67.49

FCF $3.0b B · Rev +36.9% A · D/E 0.08 A- · P/E 12.1x A- · PEG 1.12 B+

Why now. Kinross Gold Corporation, a mid-cap gold miner, is poised for growth driven by its 36.9% revenue growth rate and $3.0B in free cash flow. With a current price of $28.51 and a P/E of 12.1, the company's valuation is reasonable considering its growth prospects. The analyst consensus 1-yr target of $41.23 suggests a potential upside, driven by the company's ability to maintain its 36% profit margin and 35.5% ROE.

Moat. Kinross Gold Corporation's moat is rooted in its ability to generate high returns on equity, with an ROE of 35.5%%, driven by its 36% profit margin. The company's low debt-to-equity ratio of 0.08 provides flexibility to invest in growth initiatives, while its diversified production geographies mitigate operational risks. The gold sector's inherent pricing power, combined with Kinross's cost advantages, contributes to its durable competitive advantage.

Risk. Kinross Gold Corporation faces risks related to its high beta of 1.37, which may lead to increased volatility in its stock price. Additionally, the company's reliance on gold prices may expose it to commodity price fluctuations. The debt-to-equity ratio, although currently low at 0.08, may increase if the company takes on more debt to finance growth initiatives, potentially impacting its credit profile.

Horizon. 1-3 yr $41.23 (analyst consensus (n=11)) — fundamentals + valuation re-rating. 5 yr $45.92 at ~10% CAGR — compounding case rests on the competitive position widening. 10 yr $67.49 if current growth sustains into durable earnings power.


2. DLO — DLocal Limited · score 97

Software - Infrastructure · price $11.51 · 1Y $17.65 · 5Y $18.54 · 10Y $27.25

FCF $374m C · Rev +46.6% A · D/E 0.20 B+ · P/E 18.0x A- · PEG n/a

Why now. DLocal Limited, a software infrastructure company, is currently trading at $11.51 with a P/E of 18, indicating a reasonable valuation for its 46.6% revenue growth rate. The company's 15.8% profit margin and $374m in free cash flow demonstrate its ability to generate earnings and cash. With an analyst consensus 1-yr target of $17.65, the stock has potential for upside.

Moat. DLocal Limited's 35% ROE is driven by its ability to maintain a high profit margin in the software infrastructure sector. The company's 2.8 P/S ratio indicates a reasonable valuation for its growth prospects. Its debt-to-equity ratio of 0.2 suggests a conservative approach to leverage, allowing the company to invest in its business while minimizing risk.

Risk. DLocal Limited faces risks related to its beta of 1.02, indicating a relatively high level of market sensitivity. The company's week 52 low of $9.75 demonstrates the potential for significant price volatility. Additionally, the analyst recommendation mean of 1.7 suggests a potential for downward revisions if the company fails to meet growth expectations.

Horizon. 1-3 yr $17.65 (analyst consensus (n=10)) — fundamentals + valuation re-rating. 5 yr $18.54 at ~10% CAGR — compounding case rests on the competitive position widening. 10 yr $27.25 if current growth sustains into durable earnings power.


3. FSM — Fortuna Mining Corp. · score 97

Gold · price $9.52 · 1Y $10.95 · 5Y $15.33 · 10Y $22.54

FCF $563m C+ · Rev +39.8% A · D/E 0.11 A- · P/E 8.8x A · PEG n/a

Why now. Fortuna Mining Corp., a gold sector growth company, is currently trading at $9.52 with a 8.8 P/E ratio, indicating undervaluation. The company has a 39.8% revenue growth rate and a 31.1% profit margin, driven by its position in the gold sector. With an analyst consensus target of $14, there is potential for upside.

Moat. Fortuna Mining Corp.'s 22% ROE is driven by its pricing power in the gold sector, resulting from its diversified production and cost advantages. The company's 2.6 P/S ratio and $563m in free cash flow demonstrate its ability to generate cash and invest in its business. This moat is further supported by the company's low 0.11 debt-to-equity ratio.

Risk. The company's 2.09 beta indicates a high level of volatility, and its 8.8 P/E ratio may be elevated compared to its peers. Additionally, the company's 39.8% revenue growth rate may be difficult to sustain, and any decline in gold prices could negatively impact the company's profitability.

Horizon. 1-3 yr $10.95 (structural (no analyst coverage)) — fundamentals + valuation re-rating. 5 yr $15.33 at ~10% CAGR — compounding case rests on the competitive position widening. 10 yr $22.54 if current growth sustains into durable earnings power.


4. PICS — PicS N.V. · score 97

Software - Infrastructure · price $10.82 · 1Y $22.14 · 5Y $17.43 · 10Y $25.63

FCF $168m C · Rev +65.0% A · D/E 0.41 B · P/E 6.4x A · PEG n/a

Why now. PicS N.V., a software infrastructure company, is currently trading at a $10.82 price point with a 6.4 P/E ratio, indicating a relatively low valuation. The company has demonstrated a 65% revenue growth rate, driven by its strong position in the software infrastructure sector. With a $1.4b market cap and $168m in free cash flow, PicS N.V. has the potential for significant growth, particularly considering the analyst consensus 1-yr target of $22.14.

Moat. PicS N.V.'s durable competitive advantage stems from its ability to generate a 40.4% return on equity, driven by its pricing power and cost advantages in the software infrastructure sector. The company's 10.6% profit margin and 0.7 price-to-sales ratio also indicate a strong business model. With a debt-to-equity ratio of 0.41, PicS N.V. has a manageable debt burden, allowing it to invest in growth initiatives.

Risk. One of the primary risks facing PicS N.V. is its reliance on the software infrastructure sector, which can be subject to fluctuations in demand. Additionally, the company's 0.41 debt-to-equity ratio, while manageable, still poses a risk if interest rates rise or the company experiences a decline in cash flow. Furthermore, the lack of a PEG ratio due to unavailable forward EPS estimates creates uncertainty around the company's future growth prospects.

Horizon. 1-3 yr $22.14 (analyst consensus (n=9)) — fundamentals + valuation re-rating. 5 yr $17.43 at ~10% CAGR — compounding case rests on the competitive position widening. 10 yr $25.63 if current growth sustains into durable earnings power.


5. EXE — Expand Energy Corporation · score 95

Oil & Gas E&P · price $92.64 · 1Y $130.16 · 5Y $149.20 · 10Y $219.31

FCF $2.8b B · Rev +188.8% A · D/E 0.26 A- · P/E 6.9x A · PEG 21.99 D

Why now. Expand Energy Corporation (EXE), an Oil & Gas E&P firm, presents a compelling growth narrative with its staggering 188.8% FY YoY revenue growth, yet trades at a remarkably low P/E of 6.9. The company generates substantial free cash flow of $2.8 billion, indicating strong operational efficiency in the current energy market cycle. This setup suggests a deeply undervalued growth play, with the market potentially underestimating the durability of its high-margin production in the energy end markets.

Moat. Expand Energy's competitive advantage in the Oil & Gas E&P sector likely stems from its efficient operational structure, evidenced by a robust 24.9% profit margin. Access to high-quality, low-cost reserves and superior extraction techniques would allow it to maintain profitability even during commodity price fluctuations. A conservative balance sheet, with a debt-to-equity ratio of 0.26, provides financial flexibility to invest in new projects and withstand industry volatility.

Risk. The primary risk for Expand Energy is the inherent volatility of commodity prices, which directly impacts revenue and profitability despite its low beta of 0.35. While revenue growth is high, the extremely elevated PEG ratio of 21.99 suggests market skepticism about the sustainability of future earnings growth, potentially indicating a future deceleration that could disappoint investors. Furthermore, the company's stock has seen significant fluctuation, trading near its 52-week low of $91.02, highlighting sensitivity to market sentiment and sector-specific headwinds.

Horizon. 1-3 yr $130.16 (analyst consensus (n=25)) — fundamentals + valuation re-rating. 5 yr $149.20 at ~10% CAGR — compounding case rests on the competitive position widening. 10 yr $219.31 if current growth sustains into durable earnings power.

Value — quality at a discount

1. AU — AngloGold Ashanti plc · score 101

Gold · price $94.52 · 1Y $123.29 · 5Y $126.49 · 10Y $161.45

FCF $4.2b B · Rev +70.8% A · D/E 0.22 B+ · P/E 13.9x A- · PEG 0.78 A-

Why now. AngloGold Ashanti plc, a leading player in the Gold sector, presents a compelling value opportunity with a current price of $94.52. The company demonstrates robust operational strength, evidenced by a remarkable 70.8% revenue growth (FY YoY) and a healthy 31.1% profit margin. This strong performance, combined with a low PEG ratio of 0.78, suggests the market has yet to fully price in its consistent free cash flow generation and potential for a re-rating as gold prices remain elevated.

Moat. AngloGold Ashanti's impressive 43% ROE is a direct result of its significant cost advantages in gold extraction and processing, allowing it to maintain superior profitability within the highly capital-intensive Gold sector. The inherent barriers to entry in large-scale precious metals mining, including the immense upfront capital required for exploration and development, extensive regulatory approvals, and the scarcity of high-grade deposits, provide a durable competitive advantage. This structural positioning ensures sustained profitability and market relevance.

Risk. The primary risk for AngloGold Ashanti plc is its exposure to the inherent volatility of global gold prices, which can significantly impact its substantial $4.2B free cash flow and overall profitability. While the company maintains a conservative debt-to-equity ratio of 0.22, a prolonged downturn in commodity prices could pressure financial flexibility. Furthermore, operational disruptions common to mining, such as geological challenges or geopolitical instability in key operating regions, pose a material threat to production volumes and its impressive 31.1% profit margin.

Horizon. 1-3 yr $123.29 (analyst consensus (n=7)) — multiple re-rating thesis requires a catalyst. 5 yr $126.49 at ~6% CAGR — dividend + buyback compounding. 10 yr $161.45 if the moat survives secular pressure.


2. PDD — PDD Holdings Inc. · score 101

Internet Retail · price $86.61 · 1Y $143.28 · 5Y $115.90 · 10Y $147.94

FCF $15.6b A- · Rev +9.7% B · D/E 0.01 A · P/E 8.9x A · PEG 0.69 A-

Why now. PDD Holdings Inc. operates in the Internet Retail sector, presenting as an undervalued franchise with a compelling setup. Its current valuation, marked by a low P/E of 8.9 and a PEG Ratio of 0.69, suggests significant statistical cheapness relative to its growth profile. Despite a modest revenue growth of 9.7%, the business generates substantial free cash flow of $15.6 billion, indicating a highly efficient operation poised for potential multiple re-rating as market sentiment shifts towards profitable, cash-generative internet platforms.

Moat. PDD's competitive advantage in Internet Retail stems from its scale and operational efficiency, which drive a cost advantage in sourcing and logistics. This allows for aggressive pricing strategies that attract and retain a broad customer base, creating powerful network effects as more users and merchants join its platforms. The impressive ROE of 26.9% is a direct result of this capital-efficient model, where high transaction volumes and optimized supply chains translate directly into superior returns on invested capital.

Risk. The primary risks for PDD include intense competition within the Internet Retail sector, which could compress margins or slow revenue growth if new entrants or existing players escalate price wars. While its debt-to-equity ratio of 0.01 is exceptionally low, indicating a strong balance sheet, the company's valuation could be susceptible to broader shifts in investor appetite for internet-based businesses, potentially leading to multiple contraction from its already low P/E of 8.9. Furthermore, any changes in consumer spending patterns or digital commerce regulations in its operating markets could impact its profitability and growth trajectory.

Horizon. 1-3 yr $143.28 (analyst consensus (n=33)) — multiple re-rating thesis requires a catalyst. 5 yr $115.90 at ~6% CAGR — dividend + buyback compounding. 10 yr $147.94 if the moat survives secular pressure.


3. INCY — Incyte Corporation · score 99

Biotechnology · price $97.34 · 1Y $107.96 · 5Y $130.26 · 10Y $166.27

FCF $1.4b C+ · Rev +21.2% A- · D/E 0.01 A · P/E 13.7x A- · PEG 0.36 A

Why now. Incyte Corporation, a biotechnology firm, presents a compelling value proposition. Trading at a mere 13.7x TTM P/E, it boasts an impressive 21.2% revenue growth year-over-year, leading to a remarkably low 0.36 PEG ratio. This valuation disconnect, coupled with robust free cash flow generation, suggests the market is underappreciating its current growth trajectory and pipeline potential in developing and commercializing therapeutic solutions.

Moat. Incyte's competitive advantage in the biotechnology sector stems from its deep intellectual property portfolio and regulatory protections for its approved therapeutic compounds. This patent-protected market position allows for significant pricing power and market share in its specialized treatment areas, directly contributing to its exceptional 30.8% Return on Equity. The high R&D costs and lengthy approval processes inherent in the industry create substantial barriers to entry for new competitors.

Risk. The primary risks for Incyte, typical of the biotechnology sector, include the inherent uncertainty of clinical trial outcomes and potential regulatory setbacks from bodies like the FDA, which could delay or prevent new product approvals. Furthermore, the expiration of key patents or the emergence of superior competing therapies could erode market share and pricing power, impacting future revenue growth and profitability. While current debt is negligible at 0.01 Debt-to-Equity, reliance on a concentrated portfolio of therapies could expose the company to significant revenue volatility.

Horizon. 1-3 yr $107.96 (analyst consensus (n=24)) — multiple re-rating thesis requires a catalyst. 5 yr $130.26 at ~6% CAGR — dividend + buyback compounding. 10 yr $166.27 if the moat survives secular pressure.


4. BZ — Kanzhun Limited · score 98

Internet Content & Information · price $13.34 · 1Y $21.24 · 5Y $17.85 · 10Y $22.79

FCF $681m C+ · Rev +12.4% B+ · D/E 0.01 A · P/E 12.6x A- · PEG 0.17 A

Why now. Kanzhun Limited (BZ) is an undervalued franchise operating in the Internet Content & Information sector, specializing in online recruitment. Despite a robust profit margin of 40.1% and TTM free cash flow of $681 million against a $6.0 billion market cap, the stock trades at a compelling 12.6x P/E. This statistical cheapness, coupled with a 0.17 PEG ratio, suggests the market is underappreciating its consistent profitability and cash generation.

Moat. BZ benefits from powerful network effects inherent to its online recruitment platform. As more job seekers utilize the service, it attracts a larger pool of employers, and vice-versa, creating a self-reinforcing cycle that enhances value for all participants. This deepens its competitive moat by increasing switching costs for both employers and candidates who have built profiles and established connections on the platform, contributing to its strong 18.2% ROE.

Risk. The primary risks for BZ include potential deceleration in its 12.4% FY YoY revenue growth if broader economic conditions lead to reduced corporate hiring or increased unemployment. Furthermore, the company operates in a dynamic Internet Content & Information sector, facing ongoing competition for both user acquisition and retention, which could pressure its impressive 40.1% profit margin. While its 0.01 debt-to-equity ratio is exceptionally low, regulatory shifts impacting online platforms could introduce unforeseen operational hurdles.

Horizon. 1-3 yr $21.24 (analyst consensus (n=21)) — multiple re-rating thesis requires a catalyst. 5 yr $17.85 at ~6% CAGR — dividend + buyback compounding. 10 yr $22.79 if the moat survives secular pressure.


5. ADBE — Adobe Inc. · score 97

Software - Application · price $238.24 · 1Y $327.28 · 5Y $318.82 · 10Y $406.95

FCF $10.3b A- · Rev +10.5% B · D/E 0.58 C+ · P/E 13.9x A- · PEG 0.68 A-

Why now. Adobe Inc. (ADBE), a leader in the "Software - Application" sector, presents a compelling value proposition at its current price of $238.24. The stock trades at a P/E of just 13.9 and a PEG ratio of 0.68, indicating significant statistical cheapness for a company with a 10.5% revenue growth rate. The setup rewards patient investors anticipating a market re-rating as the company continues to generate substantial free cash flow from its indispensable application software offerings for businesses and creative professionals.

Moat. ADBE's competitive advantage stems from deep customer entrenchment and high switching costs within its core "Software - Application" markets. The company's exceptional Return on Equity (ROE) of 58.8% is a direct result of its pricing power and the mission-critical nature of its tools, which are integral to professional workflows. This enables the business to consistently convert revenue into substantial free cash flow, evidenced by $10.3b in TTM FCF, reinforcing its dominant position and ability to reinvest or return capital.

Risk. The primary risks for ADBE include its elevated market volatility, indicated by a beta of 1.42, which exposes it to outsized swings during broader market corrections. While the 10.5% revenue growth is solid, any deceleration in this figure could challenge the 'value' thesis, especially if competitive pressures intensify within the "Software - Application" sector. Furthermore, maintaining its impressive 29.5% profit margin could become more difficult if increased competition forces pricing concessions.

Horizon. 1-3 yr $327.28 (analyst consensus (n=34)) — multiple re-rating thesis requires a catalyst. 5 yr $318.82 at ~6% CAGR — dividend + buyback compounding. 10 yr $406.95 if the moat survives secular pressure.

Speculative — asymmetric upside

1. BILL — BILL Holdings, Inc. · score 90

Software - Application · price $34.70 · 1Y $55.10 · 5Y $69.79 · 10Y $181.61

FCF $327m C · Rev +13.4% B+ · D/E 0.50 B · P/S 2.2x A- · PEG 0.36 A

Why now. BILL Holdings, Inc. operates in the Software - Application sector, providing solutions that streamline financial operations for businesses. Despite a current profit margin of 0%, the company generated robust $327m in free cash flow over the TTM, indicating strong operational efficiency even as it invests for growth. Trading at a modest 2.2x P/S (TTM), this "spec" classification hinges on BILL's ability to translate its cash generation into accelerating revenue growth and sustainable GAAP profitability, a scenario that the market's current valuation seems to discount.

Moat. BILL Holdings, Inc. benefits from significant switching costs inherent in its Software - Application offerings; businesses integrating financial operations software face high friction and cost when attempting to migrate to alternative platforms. This sticky customer base, once onboarded, provides a stable revenue foundation. The platform's utility also grows with increased adoption among its small and medium business clientele, fostering a network effect as more participants streamline their payment and invoicing workflows within the ecosystem.

Risk. BILL Holdings, Inc. faces material competition within the crowded Software - Application sector, which could pressure its 13.4% revenue growth rate if rivals offer more compelling features or pricing. Its elevated Beta of 1.22 indicates higher volatility, making the stock susceptible to broader market downturns or shifts away from growth-oriented equities. Furthermore, while its debt-to-equity ratio of 0.5 is manageable, any significant increase in interest rates or a slowdown in free cash flow generation could strain its balance sheet.

Horizon. 1-3 yr $55.10 (analyst consensus (n=21)) — catalyst-driven; binary events dominate. 5 yr $69.79 — requires the platform / technology to reach commercial scale. 10 yr $181.61 — return distribution heavily skewed.


2. WIX — Wix.com Ltd. · score 89

Software - Infrastructure · price $53.46 · 1Y $86.75 · 5Y $107.53 · 10Y $279.80

FCF $505m C+ · Rev +13.2% B+ · D/E n/a · P/S 1.1x A- · PEG 0.13 A

Why now. Wix.com Ltd., operating in the Software - Infrastructure sector, provides a comprehensive platform for individuals and businesses to establish and manage their online presence. The stock currently trades at $53.46, near its 52-week low of $51.60, despite generating substantial Free Cash Flow of $505m (TTM). While the company reports a negative profit margin of -2%, its extremely low P/S ratio of 1.1 for a business growing revenue at 13.2% suggests the market is pricing in significant skepticism. The binary setup hinges on WIX converting its FCF into sustained GAAP profitability and potentially re-accelerating growth, which would likely lead to a substantial re-rating.

Moat. WIX benefits from significant switching costs; once a business builds its online infrastructure and ecosystem on the platform, migrating to a competitor involves considerable time, effort, and potential disruption to operations and SEO. The company's integrated suite of tools, encompassing website building, e-commerce, marketing, and booking solutions, creates a sticky ecosystem that increases customer lifetime value and reduces churn. This comprehensive offering lowers the barrier to entry for non-technical users, fostering a broad and loyal customer base within the online presence market.

Risk. The primary risk for WIX is the intense competitive landscape within the online presence and website builder market, which could limit pricing power and necessitate ongoing investment in product development, potentially hindering margin expansion from its current -2%. Furthermore, while revenue growth stands at 13.2%, any significant deceleration could prevent the stock from re-rating, keeping its P/S multiple suppressed. The company's status as a 'spec' category stock means it remains highly sensitive to shifts in market sentiment towards unprofitable growth names, particularly given its beta of 1.01.

Horizon. 1-3 yr $86.75 (analyst consensus (n=20)) — catalyst-driven; binary events dominate. 5 yr $107.53 — requires the platform / technology to reach commercial scale. 10 yr $279.80 — return distribution heavily skewed.


3. CRC — California Resources Corporation · score 88

Oil & Gas E&P · price $59.75 · 1Y $82.00 · 5Y $120.18 · 10Y $312.72

FCF $778m C+ · Rev +15.1% B+ · D/E 0.47 B · P/S 1.5x B+ · PEG 0.28 A

Why now. California Resources Corporation (CRC) is an Oil & Gas E&P company focused on crude oil and natural gas production. It presents a speculative setup, currently operating at a -13.4% profit margin despite robust 15.1% revenue growth. The high-risk/high-reward profile hinges on converting its substantial $778m in TTM free cash flow into sustainable net profitability, a scenario analysts view favorably with a 'strong buy' consensus.

Moat. As an established Oil & Gas E&P player, California Resources Corporation benefits from its existing, permitted asset base in a highly regulated operating environment. The significant capital expenditure and regulatory hurdles required for new entrants to establish production in such a jurisdiction create a de facto barrier to competition. This allows CRC to leverage its infrastructure and operational expertise to extract value from its long-lived reserves.

Risk. The primary risk for California Resources Corporation is its negative -13.4% profit margin, indicating a struggle to convert revenue into net income, which could persist if commodity prices decline or operating costs rise. Furthermore, the company operates in a capital-intensive sector highly susceptible to price swings in its core products, introducing significant revenue and profitability volatility. Regulatory shifts in its operating region, which could impose stricter environmental mandates or limit production, also pose a material threat to future cash flows and reserve development.

Horizon. 1-3 yr $82.00 (analyst consensus (n=11)) — catalyst-driven; binary events dominate. 5 yr $120.18 — requires the platform / technology to reach commercial scale. 10 yr $312.72 — return distribution heavily skewed.


4. INTA — Intapp, Inc. · score 87

Software - Application · price $19.14 · 1Y $34.57 · 5Y $38.50 · 10Y $100.18

FCF $128m C · Rev +17.1% B+ · D/E 0.06 A- · P/S 2.6x B+ · PEG 0.38 A

Why now. Software - Application · market cap $1.5b. Down 67% from 52-week high of $58.79 — deep drawdown territory. Revenue growing +17%, comfortably above the S&P median. PEG 0.38 — paying under fair value for the growth rate. 7 sell-side analysts publish a mean 1-yr target of $34.57 (implying +81% upside).

Moat. Software economics — recurring revenue, embedded customer workflows, and high gross margin all compound the moat once a base account is won. Switching costs are the lever.

Risk. Currently unprofitable (margin -6.5%) — path to GAAP profitability is the core thesis risk. Down 67% from the 52-week high — the market is pricing in something the screen can't see; verify the bear case before sizing up. ROE -9% is below the long-run sustainable threshold of ~10% — capital efficiency would need to improve for the equity base to compound at the market rate.

Horizon. 1-3 yr $34.57 (analyst consensus (n=7)) — catalyst-driven; binary events dominate. 5 yr $38.50 — requires the platform / technology to reach commercial scale. 10 yr $100.18 — return distribution heavily skewed.


5. BHC — Bausch Health Companies Inc. · score 86

Drug Manufacturers - Specialty & Generic · price $5.39 · 1Y $7.50 · 5Y $10.84 · 10Y $28.21

FCF $989m C+ · Rev +6.7% C+ · D/E n/a · P/S 0.2x A · PEG 0.01 A

Why now. Bausch Health Companies Inc. (BHC) presents a compelling, albeit high-risk, setup for investors willing to bet on a significant turnaround. Despite a negative -11.5% profit margin, the company generates substantial free cash flow of $989m against a modest $2.0b market cap, implying an extraordinary FCF yield. This discrepancy, combined with a deeply discounted P/S ratio of 0.2, suggests the market is heavily discounting future prospects or pricing in significant liabilities. The binary thesis hinges on management's ability to convert this FCF into sustainable profitability and debt reduction within its Drug Manufacturers - Specialty & Generic sector.

Moat. BHC's competitive advantage in the Drug Manufacturers - Specialty & Generic sector stems from the high regulatory barriers to entry and the specialized manufacturing capabilities required for its product portfolio. The company benefits from established distribution channels and the inherent stickiness of approved pharmaceutical products, which create switching costs for healthcare providers and patients. Its 'specialty' segment likely involves intellectual property or unique formulations, while its 'generic' segment relies on scale and cost-efficient production to compete effectively.

Risk. The primary risk for BHC is its persistent unprofitability, evidenced by a -11.5% profit margin, which raises concerns about long-term viability despite strong FCF generation. The 'spec' classification inherently points to significant financial leverage or operational challenges that could erode shareholder value if not managed effectively. Furthermore, the highly competitive landscape in the Drug Manufacturers - Specialty & Generic sector, coupled with potential regulatory changes or patent expirations, could further pressure revenue growth of 6.7% and hinder efforts to achieve sustainable positive earnings.

Horizon. 1-3 yr $7.50 (analyst consensus (n=6)) — catalyst-driven; binary events dominate. 5 yr $10.84 — requires the platform / technology to reach commercial scale. 10 yr $28.21 — return distribution heavily skewed.

Methodology footnote

Every pick on this list comes out of the same seven-grade quantitative model applied to every US-listed common stock with a market cap above $1B. Each pick's score breakdown is auditable from the home page — click the ticker on the rankings page to see exactly which grades and adjustments produced the number. Not investment advice. See terms for full disclosures.

Not investment advice. The Bull Rankings publishes a quantitative ranking model and accompanying analysis for general informational purposes only. Nothing on this page is a recommendation to buy, sell, or hold any security; nothing is personalized to your circumstances, risk tolerance, or tax situation. Investing carries the risk of loss — invest at your own risk and consider consulting a licensed financial professional before acting on anything you read here. See terms and methodology for full disclosures.